On January 17, several listed companies in Shanghai and Shenzhen issued announcements. The following is a summary of important announcements.
major events
Shandong Xinhua Pharmaceutical Company Limited(000756) : the two drugs of the subsidiary passed the conformity evaluation of generic drugs
Shandong Xinhua Pharmaceutical Company Limited(000756) (000756) it was announced on January 17 that Amoxicillin Capsules and pioglitazone hydrochloride capsules of Xinda pharmaceutical, a wholly-owned subsidiary, passed the conformity evaluation of generic drugs.
China Merchants Energy Shipping Co.Ltd(601872) : delivery of new super flexible multipurpose ship
China Merchants Energy Shipping Co.Ltd(601872) (601872) announced on January 17 that on January 17, the company received a 62000 DWT super flexible multi-purpose ship “Pacific endeavor” (Mingqin) in Yizheng, Yangzhou through its wholly-owned single ship company. The first voyage of “Mingqin” will load export wind power equipment. The ship is the first of the four new energy-saving and environmental protection multi-purpose ships approved by the 34th meeting of the Fifth Board of directors of the company, which is suitable for global routes.
Haisco Pharmaceutical Group Co.Ltd(002653) : hsk36273 clinical trial application for injection was accepted
Haisco Pharmaceutical Group Co.Ltd(002653) (002653) announced on January 17 that the company obtained the acceptance notice of hsk36273 clinical trial application for innovative drug injection. Hsk36273 for injection is an intravenous anticoagulant drug ep7041 introduced by the company in the early stage, Haisco Pharmaceutical Group Co.Ltd(002653) has its exclusive license in China. It is clinically intended to be used for hemodialysis and systemic anticoagulation of intraoperative patients.
China Galaxy Securities Co.Ltd(601881) : approved pilot of equity incentive exercise financing business of listed companies
China Galaxy Securities Co.Ltd(601881) (601881) announced on January 17 that recently, the company received a letter from Shenzhen Stock Exchange and agreed to carry out the pilot of equity incentive exercise financing business of listed companies.
Andon Health Co.Ltd(002432) : the monthly performance of kit products does not represent the annual performance
Andon Health Co.Ltd(002432) (002432) said on January 17 that the single month performance of the kit product does not represent the annual performance, and the historical performance of the product does not represent the future performance. The company once again reminded the company of stock trading risks, including the risk of uncertainty in the development of the epidemic in the United States; The risk of uncertainty in the development of the epidemic in the United States; Rationality risk of valuation model; Reliability risk of information; Exchange rate fluctuation risk; Logistics and transportation risks; Quality risk; Contract / order risk. It should be noted that the US government has the right to terminate the contract at any time due to its own factors.
Zhe Jiang Hua Hai Pharmaceuticalco.Ltd(600521) : the clinical trial of hb0036 injection was approved by FDA
Zhe Jiang Hua Hai Pharmaceuticalco.Ltd(600521) (600521) announced on January 17 that its subsidiary huaaotai received the notice of approval of the application for clinical trial of hb0036 injection submitted to the U.S. Food and Drug Administration (FDA).
Luoxin Pharmaceuticals Group Stock Co.Ltd(002793) : meropenem for injection passed the conformity evaluation of generic drugs
Luoxin Pharmaceuticals Group Stock Co.Ltd(002793) (002793) it was announced on January 17 that meropenem for injection, a subsidiary of the company, Shandong Luoxin, passed the consistency evaluation of generic drug quality and efficacy. Meropenem is suitable for the infection of adults and children caused by single or multiple bacteria sensitive to meropenem. It can be used alone or in combination with other antimicrobial agents to treat multiple infections.
Konka Group Co.Ltd(000016) : the holding subsidiary plans to increase capital and shares and introduce strategic investors
Konka Group Co.Ltd(000016) (000016) it was announced on January 17 that the holding Sun Company Hefei kangxinwei Storage Technology Co., Ltd. plans to increase its capital and shares by means of public listing in the state-owned property exchange, and introduce strategic investors. It is expected that the amount of capital increase will be 150-250 million yuan. Hefei kangxinwei is mainly engaged in the design and sales of memory master chips.
Add Industry(Zhejiang) Co.Ltd(603089) : Ningbo Hongyu, a wholly-owned subsidiary, resumed work and production in an orderly manner
Add Industry(Zhejiang) Co.Ltd(603089) (603089) announced on January 17 that the blockade of Ningbo Hongyu, a wholly-owned subsidiary, had been lifted. Ningbo Hongyu began to resume work and production orderly from January 17, 2022, and implemented comprehensive prevention and control measures to ensure the health of employees and the normal operation of the company.
Zhejiang Conba Pharmaceutical Co.Ltd(600572) : parecoxib sodium for injection passed the conformity evaluation of generic drugs
Zhejiang Conba Pharmaceutical Co.Ltd(600572) (600572) announced on January 17 that the holding subsidiary Jinhua Zhejiang Conba Pharmaceutical Co.Ltd(600572) received the notice of approval for supplementary application of parecoxib sodium for injection issued by the State Food and drug administration, and the drug passed the conformity evaluation of generic drugs.
Zhejiang Dayang Biotech Group Co.Ltd(003017) : projects with an annual output of 25000 tons of potassium carbonate (phased) have been completed and passed the environmental protection acceptance
Zhejiang Dayang Biotech Group Co.Ltd(003017) (003017) on January 17, it was announced that the company’s project with an annual output of 25000 tons of potassium carbonate and 15000 tons of potassium bicarbonate (phased) was completed and passed the environmental protection acceptance, indicating that the company’s comprehensive annual capacity of potassium carbonate (including potassium bicarbonate equivalent) increased from 77000 tons in 2020 to 85000 tons at the end of 2021, providing capacity support for the growth of the company’s operating performance.
Keda Industrial Group Co.Ltd(600499) : the extended application of ceramic machinery products is under way, and the existing lithium salt tunnel kiln order
Keda Industrial Group Co.Ltd(600499) (600499) said on the interactive platform that the company is actively carrying out the extended application of ceramic machinery products. There are orders for lithium salt tunnel kiln. At present, this part of the business accounts for a relatively small proportion. Lanke currently has a 20000 ton battery grade lithium carbonate production line. After the lithium precipitation unit is put into operation, it will produce battery grade lithium carbonate.
Jilin Aodong Pharmaceutical Group Co.Ltd(000623) : the holding subsidiary obtained the listing Filing Certificate of traditional Chinese medicine formula granules
Jilin Aodong Pharmaceutical Group Co.Ltd(000623) (000623) it was announced on January 17 that Yanbian pharmaceutical, the holding subsidiary of the company, obtained 91 national standard listing and filing certificates for traditional Chinese medicine formula granules, which is of great significance for the company to expand the business of traditional Chinese medicine formula granules. In the future, the company will carry out the production and sales of the above products in combination with the market situation.
Qibu Corporation Limited(603557) : the company is suspected of violating the letter Phi rules and was filed by the CSRC
Qibu Corporation Limited(603557) (603557) announced on January 17 that the CSRC decided to file a case against the company because the company was suspected of violating laws and regulations in information disclosure.
Frontier Biotechnologies Inc(688221) : the product under development fb2001 is intended to treat hospitalized patients with moderate and severe covid-19 pneumonia
Frontier Biotechnologies Inc(688221) (688221) announced on the 17th that the company’s product fb2001 under development is a covid-19 pneumonia virus protease inhibitor for injection, and the target is covid-19 pneumonia virus 3CL main protease. The product under development is intended to treat hospitalized patients with moderate and severe covid-19 pneumonia. New drug research and development is a long-term work, and the sales of new drugs after listing is affected by multiple factors. Up to now, Pfizer’s oral covid-19 drug (paxlovid) has been authorized by the U.S. Food and Drug Administration for emergency use to treat non hospitalized patients with mild to moderate covid-19 pneumonia with adverse prognosis risk.
Fujian Cosunter Pharmaceutical Co.Ltd(300436) : Anti covid-19 small molecule oral drug is still in the preclinical research stage
Fujian Cosunter Pharmaceutical Co.Ltd(300436) (300436) released a stock price announcement on the evening of January 17th, saying that the anti New Coronavirus small molecule oral Innovation Medicine project of Fujian Guangsheng Zhong Lin Biotechnology Co., Ltd., a subsidiary of the company, is still in the pre clinical research stage, and it is necessary to identify the preclinical candidate compounds (PCC) by the study of compound characterization. Complete preclinical pharmaceutical research and pharmacokinetic, pharmacodynamic, pharmacological and toxicological research in line with clinical registration declaration, and carry out phase I, II and III clinical research after obtaining the clinical (implied) license of nmpa. After obtaining the corresponding safety and efficacy data, submit the drug registration application to nmpa, obtain the drug registration certificate and pass the GMP compliance inspection of API, Only then can the project products be produced and sold.
Hunan Baili Engineering Sci & Tech Co.Ltd(603959) : the controlling shareholder intends to transfer 5% of the company’s shares
Hunan Baili Engineering Sci & Tech Co.Ltd(603959) (603959) announced on January 17 that the controlling shareholder of the company, Tibet Xinhai New Venture Capital Co., Ltd., plans to transfer 24.51 million shares of the company’s tradable shares without restrictions (accounting for 5% of the company’s total share capital) to Shanghai axing Investment Management Co., Ltd. The share transfer price is 14.99 yuan / share, and the total price is 367 million yuan. In addition, the controlling shareholder planned to transfer 6% of the company’s shares to Su Huan last September, and the equity transfer is still in progress.
Shanghai Yatong Co.Ltd(600692) : the proposed new energy company will not have a significant impact on the company’s business structure in the short term
Shanghai Yatong Co.Ltd(600692) (600692) announced on January 17 that the company plans to invest 19 million yuan to establish Shanghai Yatong New Energy Technology Co., Ltd. to carry out the construction and operation of Cecep Solar Energy Co.Ltd(000591) photovoltaic power station project in Chongming district. This investment will help the company to further explore new profit growth points. According to the company’s latest financial report, real estate development is still the company’s main business. In 2020, real estate sales accounted for 64.9% of the company’s operating revenue. The new energy company will not have a significant impact on the company’s business structure in the short term.
Shanxi Securities Co.Ltd(002500) : the holding subsidiary was sued
Shanxi Securities Co.Ltd(002500) (002500) announced on the evening of January 17 that Zhongde securities, the holding subsidiary of the company, received a civil complaint served by the Beijing Financial court. The cause of action was a dispute over the liability for Securities Misrepresentation. 2000 plaintiffs such as Shanghai Junying asset management partnership (limited partnership) filed a civil lawsuit against LETV and other 21 defendants to the Beijing Financial court, requiring LETV to compensate for the investment losses caused by its false statements, totaling 4.571 billion yuan, and requiring the other 20 defendants to bear joint and several liability. Sino German securities is one of the 21 defendants and is required to bear joint and several liability. At present, the case has not yet been heard.
Ningxia Jiaze Renewables Corporation Limited(601619) : the transaction to obtain the control of ningbai fund constitutes a major asset restructuring
Ningxia Jiaze Renewables Corporation Limited(601619) (601619) announced on January 17 that the company plans to pay cash to buy 22.7% of the limited partnership share of ningbai fund held by Shanghai gas investment. Meanwhile, Hainan Kaixian, the holding subsidiary of the company, plans to pay cash to buy 0.0463% of the general partnership share of ningbai fund held by Ningxia Kaixian. This transaction constitutes a major asset restructuring. Prior to the transaction, the company had held 77.2528% of the partnership share of ningbai fund. After the transaction, Hainan Kaixian will become the general partner of ningbai fund, and the company will hold or control 100% of the total partnership share of ningbai fund and obtain the control right of ningbai fund. The projects invested by ningbai fund are mainly wind power and photovoltaic projects.
performance express
Shanghai Tianyang Hotmelt Adhesives Co.Ltd(603330) : the net profit in 2021 is expected to increase by 103% – 112% year-on-year
Shanghai Tianyang Hotmelt Adhesives Co.Ltd(603330) (603330) announced on January 17 that the net profit in 2021 is expected to be 105-110 million yuan, a year-on-year increase of 103% – 112%. This performance increase is mainly due to non recurring profit and loss events such as the sale of idle plants, with an impact amount of about 68 million yuan. During the reporting period, the company’s overall sales revenue increased by about 53% over the same period of the previous year, and the sales revenue of photovoltaic EVA packaging film, rubber powder and rubber particles, hot-melt wall cloth, rubber film and electronic glue all increased. However, due to the sharp rise in the price of raw materials and the increase in brand publicity expenses, the net profit after deduction was basically the same as that in the same period of last year.
Shenzhen Salubris Pharmaceuticals Co.Ltd(002294) : the net profit in 2021 is expected to increase by 657% – 883%
Shenzhen Salubris Pharmaceuticals Co.Ltd(002294) (002294) disclosed the performance forecast on January 17. It is estimated that the net profit in 2021 will be 461 million yuan – 598 million yuan, with a year-on-year increase of 657% – 883.23%. In 2021, the company made a total provision for asset impairment of about 147 million yuan; In addition, it is estimated that the impact of the company’s non recurring profits and losses on the net profit is about 215 million yuan to 280 million yuan.
Shanghai Jahwa United Co.Ltd(600315) : the net profit in 2021 will increase by about 52% year-on-year
Shanghai Jahwa United Co.Ltd(600315) (600315) announced on January 17 that the company expects to realize a net profit attributable to shareholders of listed companies of about 655 million yuan in 2021, an increase of about 225 million yuan over the same period of last year, an increase of about 52% year-on-year. Among them, the net profit in the fourth quarter increased by about 99% year-on-year. The pre increase in performance is mainly due to the growth of main business.
Truking Technology Limited(300358) : the net profit in 2021 is expected to increase by 149% – 199% year-on-year
Truking Technology Limited(300358) (300358) disclosed the performance forecast on January 17. It is estimated that the net profit in 2021 will be 500 million yuan – 600 million yuan, with a year-on-year increase of 149.33% – 199.2%. In recent years, the company’s product sales has changed from stand-alone sales to the provision of overall solutions for production equipment of smart pharmaceutical industry, and is transitioning to smart pharmaceutical technology solutions. During the reporting period, the company focused on the development of biopharmaceutical equipment, basically completed the layout of biopharmaceutical front-end equipment, made great achievements in the high-end field of the market and import substitution, and greatly improved the sales and profit level.
Xinjiang Tianye Co.Ltd(600075) : the product price rises sharply, and the performance in 2021 is expected to increase by 80% to 97%
Xinjiang Tianye Co.Ltd(600075) (600075) announced on January 17 that it is preliminarily estimated that the net profit attributable to the parent company in 2021 is expected to be 1.6 billion yuan to 1.75 billion yuan, an increase of 80% to 97% year-on-year. In 2021, the market prices of PVC resin, caustic soda and other products increased significantly, and the operating profit margin and net profit of the company increased significantly year-on-year due to the combined influence of the merger and acquisition of subsidiaries under the same control.
Ningxia Western Venture Industrial Co.Ltd(000557) : the net profit in 2021 is expected to increase by 36.3% year-on-year
Ningxia Western Venture Industrial Co.Ltd(000557) (000557) disclosed the performance forecast on January 17. It is estimated that the net profit in 2021 will be 234 million yuan, with a year-on-year increase of about 36.3%. During the reporting period, the railway traffic volume increased by about 16% compared with that in 2020, and the transportation revenue and profit increased accordingly; Non recurring profit and loss items such as bad debt provision for other receivables and accounts receivable, tax rebate and profit and loss on disposal of non current assets have a total impact on the net profit of about 7.69 million yuan in 2021.
Dongguan Winnerway Industry Zone Ltd(000573) : it is estimated that the net profit in 2021 will be 125 million to 180 million yuan, and the loss will be reversed year-on-year
Dongguan Winnerway Industry Zone Ltd(000573) (000573) disclosed the performance forecast on January 17. It is estimated that the net profit in 2021 will be 125 million yuan – 180 million yuan, turning losses into profits year-on-year. During the reporting period, the sold commercial houses of Dongguan diting mountain garden, a self operated real estate project, were delivered successively, meeting the revenue recognition conditions, and the revenue in the current period is expected to increase year-on-year; At the same time, the sold products of equity cooperation projects were settled, and the investment income increased.
Chtc Helon Co.Ltd(000677) : the net profit in 2021 is expected to increase by 940% – 1215%
Chtc Helon Co.Ltd(000677) (000677) announced on January 17 that the net profit in 2021 is expected to be 68-86 million yuan, a year-on-year increase of 939.72% – 1214.94%. During the reporting period, the holding subsidiary Shandong Hailong Bolet Chemical Fiber Co., Ltd. was in short supply in the curtain canvas industry market, and its operation showed a prosperous situation of production and marketing.
Tongling Nonferrous Metals Group Co.Ltd(000630) : the net profit in 2021 is expected to increase by 260.44% year-on-year
Tongling Nonferrous Metals Group Co.Ltd(000630) (000630) announced on January 17 that the net profit in 2021 is expected to be 3.12 billion yuan, a year-on-year increase of 260.44%. During the reporting period, the prices of cathode copper, sulfuric acid, iron pellets and other main products increased significantly year-on-year, and the copper foil processing fee continued to rise.
Baotailong New Materials Co.Ltd(601011) : the net profit in 2021 is expected to increase by 170.76% to 208.1%
Baotailong New Materials Co.Ltd(601011) (601011) announced on January 17 that the net profit in 2021 is expected to be 145 million yuan – 165 million yuan, with a year-on-year increase of 170.76% to 208.1%. In 2021, the prosperity of the coking industry was better, the selling prices of the company’s main products increased significantly year-on-year, and the comparison base of the previous year was small.
Hangzhou Lion Electronics Co.Ltd(605358) : the net profit in 2021 will increase by 192.14 to 216.9% year-on-year
Hangzhou Lion Electronics Co.Ltd(605358) (605358) announced on January 17 that the net profit in 2021 is expected to be 590 million yuan – 640 million yuan, with a year-on-year increase of 192.14 to 216.9%. The company’s industry and market scene continues to improve, the market demand is strong, the company’s sales orders are full, the production capacity is continuously released, and the production and sales of main products have increased significantly.
Bank Of Ningbo Co.Ltd(002142) performance express: net profit in 2021 increased by 29.67% year-on-year
Bank Of Ningbo Co.Ltd(002142) (002142) disclosed the performance express on January 14. In 2021, the operating revenue was 52.721 billion yuan, a year-on-year increase of 28.24%; The net profit was 19.515 billion yuan, a year-on-year increase of 29.67%; The basic earnings per share is 3.12 yuan. By the end of 2021, the company’s non-performing loan ratio was 0.77%, down 0.02 percentage points from the end of the previous year.
Wanhua Chemical Group Co.Ltd(600309) : the net profit in 2021 is expected to increase by 139% – 151%
Wanhua Chemical Group Co.Ltd(600309) (600309) announced on January 17 that the net profit in 2021 is expected to be 24 billion yuan to 25.2 billion yuan, with a year-on-year increase of 139% to 151%; Earnings per share ranged from 7.64 yuan to 8.03 yuan. During the reporting period, the price of chemical products increased. The company’s MDI technical transformation, ethylene and other new production capacity and new devices were put into operation, the volume and price of main products such as polyurethane, petrochemical and fine chemicals increased simultaneously, and the operating performance increased significantly year-on-year.
Bros Eastern Co.Ltd(601339) : the net profit in 2021 is expected to increase by 263% – 280% year-on-year
Bros Eastern Co.Ltd(601339) (601339) announced on January 17 that the net profit in 2021 is expected to be 1.33 billion yuan to 1.39 billion yuan, a year-on-year increase of 263% – 280%. In 2021, the company’s overall production capacity will return to the pre epidemic level, capacity utilization will be improved, orders will be increased and profits from main businesses will increase.
Beijing Easpring Material Technology Co.Ltd(300073) : the net profit in 2021 is expected to increase by 159% – 172%
Beijing Easpring Material Technology Co.Ltd(300073) (300073) disclosed the performance forecast on January 17. It is expected to make a profit of 1-1.05 billion yuan in 2021, with a year-on-year increase of 159% – 172%. After the completion of the company’s new production capacity, it will be put into operation at full capacity, and the sales volume of lithium battery cathode materials will increase significantly year-on-year in 2021; High nickel products have achieved rapid and large-scale production, and the overall profitability of the products has been steadily improved.
Eastroc Beverage (Group) Co.Ltd(605499) : the net profit in 2021 is expected to increase by 42% – 54% year-on-year
Eastroc Beverage (Group) Co.Ltd(605499) (605499) announced on January 17 that the net profit in 2021 is expected to be 1.15 billion yuan – 1.25 billion yuan, with a year-on-year increase of 41.61% – 53.93%. The company’s sales revenue in 2021 increased significantly compared with the same period of last year.
Amlogic (Shanghai) Co.Ltd(688099) : the net profit in 2021 is expected to increase by 579% – 631%
Amlogic (Shanghai) Co.Ltd(688099) (688099) announced on January 17 that it is expected that the net profit in 2021 will be 780-840 million yuan, with a year-on-year increase of 579.24% – 631.49%. In 2021, the company’s shipments of intelligent set-top box chips and AI audio and video system terminal chips increased rapidly. The company accelerated the introduction of new products, significantly increased the shipment of WiFi Bluetooth chips, and began to contribute to the operating revenue.
Haibo Heavy Engineering Science And Technology Co.Ltd(300517) : the net profit in 2021 is expected to increase by 79% – 99% year-on-year
Haibo Heavy Engineering Science And Technology Co.Ltd(300517) (300517) disclosed the performance forecast on January 17. It is estimated that the net profit in 2021 will be 93.116 million yuan – 103 million yuan, with a year-on-year increase of 79.4% – 99.4%. During the reporting period, the company’s operation was stable, resulting in an increase in operating revenue over the same period of last year.
Chengdu Wintrue Holding Co.Ltd(002539) : the net profit in 2021 is expected to increase by 141% – 151%
Chengdu Wintrue Holding Co.Ltd(002539) (002539) disclosed the performance forecast on January 17. It is estimated that the net profit in 2021 will be RMB 1.2 billion-1.25 billion, with a year-on-year increase of 140.7% – 150.72%. During the reporting period, the sales volume and gross profit margin of the company’s compound fertilizer products increased year-on-year; The sales prices of United alkali products and phosphorus chemical products increased year-on-year, and the gross profit margin increased year-on-year.
Guangzhou Tinci Materials Technology Co.Ltd(002709) : the net profit in 2021 is expected to increase by 294% – 332%
Guangzhou Tinci Materials Technology Co.Ltd(002709) (002709) disclosed the performance forecast on January 14. It is estimated that the net profit in 2021 will be RMB 2.1 billion-2.3 billion, with a year-on-year increase of 294.09% – 331.62%. During the reporting period, the sales volume and price of lithium-ion battery material electrolyte products of the company increased significantly year-on-year, the self-production rate of raw materials of the company’s products increased continuously, and the overall profitability improved significantly.
Sichuan Em Technology Co.Ltd(601208) : the net profit in 2021 will increase by about 99.72% to 116.81% year-on-year
Sichuan Em Technology Co.Ltd(601208) (601208) announced on January 17 that the net profit in 2021 is expected to increase by about 175 million yuan to 205 million yuan compared with the same period of last year, with a year-on-year increase of about 99.72% to 116.81%.
Jiangsu Shagang Co.Ltd(002075) : the net profit in 2021 is expected to increase by 39% – 87% year-on-year
Jiangsu Shagang Co.Ltd(002075) (002075) disclosed the performance forecast on January 17. It is estimated that the net profit in 2021 will be RMB 900 million-1.215 billion, with a year-on-year increase of 38.56% – 87.06%. In 2021, the overall operation trend of the iron and steel industry is good.
Delixi Xinjiang Transportation Co.Ltd(603032) : the pre profit in 2021 is 80 million to 110 million yuan, and the loss is reversed year-on-year
Delixi Xinjiang Transportation Co.Ltd(603032) (603032) disclosed the performance forecast on January 17. It is estimated that the net profit in 2021 will be 80 million yuan – 110 million yuan, turning losses into profits year-on-year. The company is committed to creating a business development model of “intelligent manufacturing + transportation”. In 2021, the sales scale of the company’s mold business continued to expand, resulting in the growth of sales revenue and the steady increase of the company’s performance. In 2021, the epidemic situation was effectively controlled, and the company’s transportation business and tourism passenger transport were improved.
Sinocare Inc(300298) : the net profit in 2021 is expected to decrease by 25% – 45%
Sinocare Inc(300298) (300298) announced on January 17 that the net profit in 2021 is expected to be 103 million yuan to 140 million yuan, a year-on-year decrease of 25% – 45%. In 2021, the bad debt of the business of Cuba TiSA company is fully withdrawn according to the remaining part of individual accounts receivable, which is expected to affect the company’s net profit of about 64.39 million yuan; Shenzhen Xinnuo Health Industry Investment Co., Ltd., a joint-stock subsidiary, is expected to have an impact on the company’s investment income of – 70 million to – 73 million yuan; It is estimated that the provision for inventory falling price is 30 million yuan; It is estimated that the total impairment of goodwill and long-term equity investment is 12 million to 20 million yuan.
Chimin Health Management Co.Ltd(603222) : the pre profit in 2021 is 140 million to 155 million yuan, with a large year-on-year increase
Chimin Health Management Co.Ltd(603222) (603222) announced on January 17 that the net profit in 2021 is expected to be 140-155 million yuan, an increase of 134-149 million yuan compared with the same period of last year. The net profit increased significantly. First, the net profit scale of the company was low due to the provision of goodwill impairment and litigation losses in the previous year; Second, the company’s safety syringe business increased significantly this year; Third, the company recognized the investment income from the disposal of Yuncheng new friendship hospital, and Ezhou No. 2 hospital offset part of the litigation losses accrued in the early stage.
Fspg Hi-Tech Co.Ltd(000973) : the net profit in 2021 is expected to increase by 42% – 84% year-on-year
Fspg Hi-Tech Co.Ltd(000973) (000973) released the performance forecast on January 17. It is estimated that the net profit in 2021 will be RMB 100 million-130 million, with a year-on-year increase of 41.53% – 83.98%. During the reporting period, the company focused on the development orientation of new material industry, actively expanded the application field of product market, and achieved significant growth in business performance.
Bus Online Co.Ltd(002188) : the pre profit in 2021 is 126 million to 176 million yuan, and the loss is reversed year-on-year
Bus Online Co.Ltd(002188) (002188) disclosed the performance forecast on January 17. It is estimated that the net profit in 2021 will be 126 million yuan – 176 million yuan, turning losses into profits year-on-year. During the reporting period, the company’s related party Zhongtian Meihao Group Co., Ltd. donated its 100% equity of Zhongtian Meihao service to the company free of charge. The business scale of donated assets increased rapidly, which had a great impact on the profit data. The acquisition and relocation of the company’s land and buildings has a great impact on the profit data of the current period. The company reversed the estimated liabilities of 19 million yuan due to winning the lawsuit, settlement and other reasons.
Hefei Fengle Seed Co.Ltd(000713) : the net profit in 2021 is expected to increase by 247% – 297%
Hefei Fengle Seed Co.Ltd(000713) (000713) disclosed the performance forecast on January 17. It is estimated that the net profit in 2021 will be 175-200 million yuan, with a year-on-year increase of 247.19% – 296.79%. Due to the influence of land collection and storage and other factors, the non recurring profit and loss in the reporting period increased by 105 million yuan to 120 million yuan year-on-year. The recurring profit and loss increased by 20-30 million yuan year-on-year, mainly due to the large increase in the sales revenue of the company’s seed business and the year-on-year increase in net profit; Due to the increased investment in environmental protection and other factors, the net profit of agrochemical business decreased year-on-year.
Suzhou Sushi Testing Group Co.Ltd(300416) : the net profit in 2021 will increase by 40% – 60% year-on-year
Suzhou Sushi Testing Group Co.Ltd(300416) (300416) disclosed the performance forecast on January 17. It is estimated that the net profit in 2021 will be 173-197 million yuan, with a year-on-year increase of 40% – 60%. During the reporting period, the business of comprehensive environmental test equipment and environmental reliability test service grew rapidly, the proportion of test service business in main business income further increased, and the profitability of IC Verification and analysis service business increased significantly.
Crystal Clear Electronic Material Co.Ltd(300655) : it is expected that the net profit in 2021 will increase by 121% – 186%
Crystal Clear Electronic Material Co.Ltd(300655) (300655) disclosed the performance forecast on January 17. It is estimated that the net profit in 2021 will be 170-220 million yuan, with a year-on-year increase of 120.92% – 185.9%. During the reporting period, benefiting from the acceleration of domestic substitution process in China’s semiconductor material industry and the rapid development of new energy vehicle industry, downstream customers have strong demand for products. The production and sales of the company’s main products such as semiconductor grade photoresist and supporting materials, high-purity reagents and lithium battery materials are booming, with a large year-on-year growth and improved overall profitability.
major investment
Zhejiang Xianju Pharmaceutical Co.Ltd(002332) : it is proposed to build a production line of 20 million injections and 200 million capsules
Zhejiang Xianju Pharmaceutical Co.Ltd(002332) (002332) announced on January 17 that it is planned to invest in the construction of a production line with an annual output of 20 million injections and 200 million capsules, with a total planned investment of 120 million yuan. After the completion of the project, it is conducive to the development of the company’s products in the direction of preparation innovative products with good curative effect, low competition and high barriers, and enrich the preparation product line. In addition, it is proposed to publicly transfer 61.2% equity of Haisheng pharmaceutical, a holding subsidiary. Haisheng pharmaceutical is mainly engaged in vitamin D3 API manufacturing, food additive manufacturing, etc., and has no synergistic effect with the steroid hormone industry chain of the company.
Shandong Jiangquan Industry Co.Ltd(600212) : disclose the plan for the sale of major assets and plan to withdraw from the thermal power business
Shandong Jiangquan Industry Co.Ltd(600212) (600212) on January 17, it disclosed the plan for the sale of major assets, and planned to transfer the thermoelectric business asset group owned by the company to Linyi Xuyuan Investment Co., Ltd. in cash; At present, the audit and evaluation related to the transaction have not been fully completed, and it is expected that there will be a major asset restructuring. After the completion of the transaction, the company will strategically withdraw from the thermal power business, concentrate resources on strategic and business transformation, and focus on the business layout focusing on new energy charging and energy storage business.
Lb Group Co.Ltd(002601) : it is proposed to invest in projects such as electronic grade lithium iron phosphate with an annual output of 150000 tons
Lb Group Co.Ltd(002601) (002601) it was announced on January 17 that Hubei bailiwanrun new energy Co., Ltd., the holding subsidiary of the company, plans to invest 2 billion yuan in the construction of an electronic grade lithium iron phosphate project with an annual output of 150000 tons; Longbai Xiangyang, a wholly-owned subsidiary, plans to invest 1 billion yuan in the construction of a post-treatment project with an annual output of 200000 tons of titanium dioxide; Yunnan Guoti, a holding subsidiary, plans to invest 441 million yuan to build an innovation project for the upgrading and transformation of 10000 tons of sponge titanium production line.
Guangzhou Development Group Incorporated(600098) : it is proposed to invest 1.4 billion yuan in agricultural photovoltaic power generation project in Changshun County
Guangzhou Development Group Incorporated(600098) (600098) announced on January 17 that GF new energy, a wholly-owned subsidiary of the company, signed the investment and development agreement with Changshun county government of Qiannan Buyei and Miao Autonomous Prefecture. Guangfa new energy Changshun agricultural photovoltaic power generation project plans to build a ground centralized 350000 kW agricultural photovoltaic power generation project with a total investment of 1.4 billion yuan. A total of 4 photovoltaic electric fields will be implemented in two phases. The project will be completed within 12 months.
Zhejiang Hailiang Co.Ltd(002203) : the investment fund increased capital of honeycomb energy by 322 million yuan
Zhejiang Hailiang Co.Ltd(002203) (002203) announced on January 17 that Hangzhou Hanzhi, the company’s investment fund, increased the capital of honeycomb energy with RMB 322 million, accounting for 0.7% of its equity after the capital increase. As a limited partner, the company contributed RMB 100 million, accounting for 19.96% of the total subscribed capital of Hangzhou Hanzhi. At present, honeycomb energy is one of the major new energy power battery enterprises in China. Hangzhou Hanzhi’s investment is in line with the investment direction of the fund, and is conducive to strengthening the cooperation between the company and enterprises in the new energy industry and accelerating the development of the company in the new energy field, especially copper foil business.
refinancing
Liuzhou Liangmianzhen Co.Ltd(600249) : it is proposed to participate in Citic Securities Company Limited(600030) share allotment of no more than RMB 18.75 million
Liuzhou Liangmianzhen Co.Ltd(600249) (600249) announced on January 17 that it is planned to use no more than 18.75 million yuan to participate in Citic Securities Company Limited(600030) share allotment and subscribe no more than 1299000 shares.
Sailun Group Co.Ltd(601058) : the proposed issuance of convertible bonds will raise no more than 2.06 billion yuan
Sailun Group Co.Ltd(601058) (601058) announced on January 17 that the company plans to raise no more than RMB 2.06 billion by issuing convertible bonds, which will be used for the annual output of 3 million sets of semi steel radial tires, 1 million sets of all steel radial tires and 50000 tons of off-road tires in Vietnam and 9 million sets of semi steel radial tires in Cambodia.
Bozhon Precision Industry Technology Co.Ltd(688097) : it is proposed to raise no more than 1.7 billion yuan to expand and improve the main business
Bozhon Precision Industry Technology Co.Ltd(688097) (688097) announced on January 17 that it is planned to raise no more than 1.7 billion yuan for automatic equipment expansion and construction projects in the new energy industry, automatic equipment upgrading projects in the consumer electronics industry, new R & D center projects and supplementary working capital. The raised investment project is the expansion and improvement of the company’s main business.
Vantone Neo Development Group Co.Ltd(600246) : it is proposed to repurchase shares of RMB 150 million to RMB 300 million
Vantone Neo Development Group Co.Ltd(600246) (600246) announced on January 17 that it is planned to repurchase shares with RMB 150 million to RMB 300 million, the repurchase price shall not exceed RMB 15.16/share, and all the repurchased shares will be used for employee stock ownership plan or equity incentive.
Myhome Real Estate Development Group Co.Ltd(000667) : early termination of repurchase of company shares
Myhome Real Estate Development Group Co.Ltd(000667) (000667) announced on January 17 that the company originally planned to repurchase shares of RMB 100 million to RMB 200 million. According to the company’s current operation and capital status, in order to ensure the company’s sustainable operation ability and debt performance ability, the company decided to terminate the repurchase of shares in advance and give priority to the use of funds for daily operating expenses and rigid debt repayment. Up to now, the company has bought back 0.93% of the shares, and the total payment (excluding transaction expenses) is 39.9951 million yuan.
Jiangsu Huachang Chemical Co.Ltd(002274) : termination of share repurchase scheme and exemption of repurchase related commitments
Jiangsu Huachang Chemical Co.Ltd(002274) (002274) announced on January 17 that the company plans to terminate the share repurchase scheme and exempt the repurchase related commitments, which needs to be submitted to the general meeting of shareholders for deliberation. The actual total repurchase amount of the company was 62.6854 million yuan, which did not reach the lower limit of the planned amount of the repurchase plan of 150 million yuan. On the trading day before the announcement disclosure date, the closing price of the company’s shares was 12.42 yuan / share, which was 7.4 yuan / share higher than the upper limit of the repurchase price; In addition, the follow-up will involve window periods such as annual performance forecast and performance express, and the company’s shares shall not be repurchased according to regulations; The above matters essentially constitute that the share repurchase scheme cannot be continued.
increase and decrease
Shanghai Zj Bio-Tech Co.Ltd(688317) : Panxin investment and Ningbo ruidao plan to reduce their total holdings of no more than 6% shares
Shanghai Zj Bio-Tech Co.Ltd(688317) (688317) announced on January 17 that due to its own capital needs, the company’s shareholder Panxin investment plans to reduce its holdings of no more than 9735200 shares of the company through centralized bidding, that is, no more than 5% of the total shares of the company. Due to the need of capital arrangement, Ningbo ruidao, the shareholder of the company, plans to reduce the shares of the company by means of centralized bidding to no more than 1947000 shares, that is, no more than 1% of the total shares of the company.
Uroica Precision Information Engineering Co.Ltd(300099) : controlling shareholders and persons acting in concert terminate the reduction plan in advance
Uroica Precision Information Engineering Co.Ltd(300099) (300099) announced on January 17 that Wang Jinghua, the controlling shareholder of the company, and Huang Ziwei, the person acting in concert, terminated the plan to reduce the company’s shares by no more than 2% in advance. Up to now, Wang Jinghua and Huang Ziwei have not reduced their shares in the company in any way.
Shenzhen Emperor Technology Company Limited(300546) : Gao Jing, the actual controller, plans to reduce no more than 2% of the company’s shares
Shenzhen Emperor Technology Company Limited(300546) (300546) announced on January 17 that Gao Jing, the controlling shareholder and actual controller of the company, plans to reduce no more than 2.7163 million shares of the company (accounting for 2% of the total share capital of the company) by means of centralized bidding within 6 months after 15 trading days.
Hamaton Automotive Technology Co.Ltd(300643) : Fuyang Jintong plans to reduce no more than 3.94% of the company’s shares
Hamaton Automotive Technology Co.Ltd(300643) (300643) announced on January 17 that Hangzhou Fuyang Jintong equity investment partnership (hereinafter referred to as “Fuyang Jintong”), a shareholder holding 3.94%, plans to reduce a total of no more than 9072600 shares (accounting for 3.94% of the total share capital of the company) through centralized bidding or block trading.
Jiangsu Broadcasting Cable Information Network Corporation Limited(600959) : shijingcheng communication plans to liquidate and reduce its shares of the company
Jiangsu Broadcasting Cable Information Network Corporation Limited(600959) (600959) announced on January 17 that the shareholder shijingcheng communication (Shanghai) Co., Ltd. (formerly known as ” Citic Guoan Information Industry Co.Ltd(000839) Communication Co., Ltd.” and now renamed, hereinafter referred to as “shijingcheng communication”) with a shareholding of 4.999995% intends to reduce the shares of the company by no more than 4.9995%.
Synthesis Electronic Technology Co.Ltd(300479) : the controlling shareholder intends to reduce no more than 3% of the company’s shares
Synthesis Electronic Technology Co.Ltd(300479) (300479) announced on January 17 that the controlling shareholder Shensi technology investment plans to reduce its holding of no more than 3% of the company’s shares.
Shanghai Longyun Cultural Creation & Technology Group Co.Ltd(603729) : the shareholder Zhuo Shuying and the persons acting in concert intend to increase their holdings of the company’s shares
Shanghai Longyun Cultural Creation & Technology Group Co.Ltd(603729) (603729) announced on January 17 that Zhuo Shuying, a shareholder holding more than 5% of the company’s shares, and the persons acting in concert intend to increase their holdings of no less than 1% of the company’s shares by means of centralized bidding transaction, and there is no price range for this increase.
Jiangxi Tianli Technology Inc(300399) : shareholders and executives plan to reduce their total holdings of no more than 4.12% shares
Jiangxi Tianli Technology Inc(300399) (300399) announced on January 17 that the company’s shareholders Tianjin Zhihui and Qian Yongmei, and the company’s director and general manager Kuang Qing planned to reduce the company’s shares by no more than 4.12%.
Anhui Sinonet & Xinlong Science & Technology Co.Ltd(002298) : the controlling shareholders and directors plan to reduce their total holdings of no more than 4% shares
Anhui Sinonet & Xinlong Science & Technology Co.Ltd(002298) (002298) it was announced on January 17 that Qu Honggui, the controlling shareholder of the company, plans to reduce his holdings of no more than 14.8 million shares (accounting for 2% of the total share capital of the company) through centralized bidding within 6 months after 15 trading days; Shu Longsheng, the director of the company, plans to reduce no more than 14.8 million shares of the company (accounting for 2% of the total share capital of the company) through centralized bidding within 6 months after 15 trading days.
Chunghsin Technology Group Co.Ltd(603996) : pre loss of 400 million to 450 million yuan in 2021
Chunghsin Technology Group Co.Ltd(603996) (603996) disclosed the performance forecast on January 17. It is estimated that the loss in 2021 will be 400 million yuan – 450 million yuan, mainly due to the credit impairment loss of 191 million yuan and the interest expense of 184 million yuan. According to preliminary accounting, the audited net profit of the company in 2021 may be negative, the operating income may be less than 100 million yuan, and the net assets at the end of the period may be negative. Meanwhile, after preliminary communication with the audit institution, the company’s 2021 financial report may continue to be issued with non-standard audit opinions. According to relevant regulations, the listing of the company’s shares may be terminated by Shanghai Stock Exchange.
sign the contract
Shuangliang Eco-Energy Systems Co.Ltd(600481) : signed a silicon wafer procurement framework contract with Tongwei Cecep Solar Energy Co.Ltd(000591)
Shuangliang Eco-Energy Systems Co.Ltd(600481) (600481) announced on January 17 that the wholly-owned subsidiary Shuangliang silicon materials (Baotou) Co., Ltd. signed a silicon wafer procurement framework contract with Tongwei Cecep Solar Energy Co.Ltd(000591) (Chengdu) Co., Ltd. the contract agreed to purchase 1.048 billion monocrystalline silicon wafers from the wholly-owned subsidiary of the company from January 2022 to December 2024, with an estimated sales amount of 6.305 billion yuan.
Fujian Minfa Aluminium Co.Ltd(002578) : signed a strategic cooperation framework agreement with Yiwei automobile
Fujian Minfa Aluminium Co.Ltd(002578) (002578) announced on January 17 that it signed a strategic cooperation framework agreement with Yiwei automobile, and the two sides reached key cooperation intentions in the fields of advanced automotive aluminum processing technology, body lightweight and other cutting-edge technology research and development, as well as related products and services.
Shenzhen Jinjia Group Co.Ltd(002191) : the subordinate companies signed a strategic cooperation agreement with you and our industry
Shenzhen Jinjia Group Co.Ltd(002191) (002191) it was announced on January 17 that Yunnan yunshuo Technology Co., Ltd., a subsidiary of the company, recently signed a memorandum of strategic cooperation agreement with Shenzhen youwo Industry Co., Ltd. Hu Xin and Wang Tao, the shareholders of yunshuo technology, plan to transfer 8% of the equity of yunshuo Technology to you and our industry. Yunshuo technology has reached strategic cooperation and equity transfer with you and our industry, which is another close cooperation between the company and you and our group after jointly promoting the R & D and production of e-cigarettes.
Shenzhen Kexin Communication Technologies Co.Ltd(300565) : the Finnish subsidiary signed an order of $9.91 million for network energy products
Shenzhen Kexin Communication Technologies Co.Ltd(300565) (300565) announced on January 17 that efore Telecom Finland oy, a Finnish subsidiary of the company, recently signed an order for network energy products with international a customers. The order amount is USD 9.9105 million (excluding tax), about RMB 62.9733 million.
winning project
Unittec Co.Ltd(000925) : won the bid for the signal system procurement project of RMB 284 million
Unittec Co.Ltd(000925) (000925) announced on January 17 that the company won the bid for the signal system procurement project of phase I and phase II of Chuzhou Nanjing Intercity Railway (Chuzhou section), with the target amount of RMB 284 million.
Shenzhen Wenke Landscape Co.Ltd(002775) : won the bid for 198 million yuan Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) barren mountain greening project
Shenzhen Wenke Landscape Co.Ltd(002775) (002775) announced on January 17 that the consortium composed of the company and Qingdao liberal arts ecological construction and Development Co., Ltd., a wholly-owned subsidiary of the company, won the bid of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) barren mountain greening project (general contracting for design and construction), with a bid price of 198 million yuan and a construction period of 195 days.
Palm Eco-Town Development Co.Ltd(002431) : won the bid of RMB 568 million PPP project for comprehensive upgrading of municipal facilities
Palm Eco-Town Development Co.Ltd(002431) (002431) announced on January 17 that the company won the bid for the PPP project for comprehensive improvement of urban municipal facilities in Qibin District, Hebi City. The estimated total PPP investment of the project is 568 million yuan, accounting for 11.79% of the company’s operating revenue in 2020. The cooperation period of the project is 15 years, including 2 years of construction period and 13 years of operation period.
business data
Fortune Ng Fung Food (Hebei) Co.Ltd(600965) : by the end of the third quarter of 2021, the revenue of prefabricated vegetable business accounted for 24.53%
Fortune Ng Fung Food (Hebei) Co.Ltd(600965) (600965) issued a change announcement on January 17, saying that after verification, the fast food branch subordinate to the company has the business of prefabricated vegetables. In 2019, the operating revenue and gross profit of the prefabricated vegetable business accounted for 22.6% and 22.16% of the company’s overall revenue respectively; Accounting for 25.17% and 37.35% respectively in 2020; By the end of the third quarter of 2021, it accounted for 24.53% and 13.19% respectively. From 2019 to 2021, the company’s Prefabricated vegetable business developed steadily. The company did not expand the production capacity and scale of the prefabricated vegetable business of fast food branch, and has maintained a stable development level.
